Lonza Group reported CHF17.36B in Assets for its second fiscal semester of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Akzo Nobel AKZA:NA EUR 14.74B 796M
Alcon AG ALC:SW USD 29.21B 1.41B
AstraZeneca AZN:LN USD 96.48B 2.3B
BASF BAS:GR EUR 84.47B 12.56B
Bayer BAYN:GR EUR 124.88B 6.13B
Covestro 1COV:GR EUR 14.58B 1.61B
Fresenius FRE:GR EUR 76.42B 3.91B
Genmab GEN:DC DKK 30.28B 408M
Givaudan GIVN:VX CHF 11.51B 405M
GlaxoSmithKline GSK:LN GBP 60.15B 167M
GN Store Nord GN:DC DKK 30.59B 488M
Hikma Pharmaceutical HIK:LN USD 4.47B 276M
Johnson Matthey JMAT:LN GBP 6.86B 195M
Merck MRK:GR EUR 48.53B 2.41B
Novartis NOVN:VX USD 117.45B 1.01B
Roche Holding ROG:VX 88.15B 1.42B
Smith & Nephew PLC SN/:LN 10.1B 815M
William Demant Holding WDH:DC DKK 29.86B 2.52B